Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.43), $0.05 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.